SPRO- Spero Therapeutics, Inc.

Name: Spero Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Spero Therapeutics, Inc. (SPRO) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 17 sells. SPRO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Rajavelu Esther	986.9K	$2.44M	-25,240
COO	Keutzer Timothy	742.5K	$1.84M	-
Dir	Mahadevia Ankit	703.3K	$1.74M	-
Dir	Deshpande Milind	91.5K	$226.3K	-
Dir	Tregoning Kathleen	75.0K	$185.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 24, 2021	Aquilo Capital Management, LLC	10% Owner	Buy	399,195	$15.51	$6,192,042.14	+3.3%	-0.7%	-94.2%
Feb 8, 2021	Aquilo Capital Management, LLC	10% Owner	Sell	3,000	$21.74	$65,215.20	-	-	-
Feb 4, 2021	Aquilo Capital Management, LLC	10% Owner	Sell	100,000	$19.02	$1,901,987.34	-0.6%	-	-
Dec 17, 2020	Aquilo Capital Management, LLC	10% Owner	Sell	264,933	$18.80	$4,981,259.54	-3.2%	-	-
Dec 16, 2020	Larkin Cristina	Chief Operating Officer	Sale+OE	12,000	$19.00	$228,000.00	-88.9%	-	-
Nov 9, 2020	Aquilo Capital Management, LLC	10% Owner	Sell	125,900	$13.77	$1,734,071.06	-2.9%	-	-
Nov 6, 2020	Aquilo Capital Management, LLC	10% Owner	Sell	174,100	$14.09	$2,452,947.51	-1.3%	-	-
Nov 4, 2020	Mahadevia Ankit58	CEO And President	Sale+OE	9,507	$14.39	$136,824.74	-6.7%	-	-
Oct 23, 2020	Mahadevia Ankit58	CEO And President	Sale+OE	20	$14.25	$285.00	-	-	-
Oct 14, 2020	Mahadevia Ankit58	CEO And President	Sale+OE	14,472	$14.28	$206,708.73	-9.9%	-	-

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC